|
|
Infliximab concentration is predictive of control of disease activity and maintenance of treatment in rheumatoid arthritis.
Lin D. Chu Miow
,
Emilie Ducourau
,
Denis Mulleman
,
P. Emond
,
Denis Ternant
,
et al.
Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. Suppl. II:177 (THU-0131)
Communication dans un congrès
hal-00320106v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Adalimumab trough serum levels and clinical response in a single-center cohort of inflammatory bowel disease patients: Can trough serum levels serve as a predictor for Future Loss of Response?
K. Karmiris
,
Gilles Paintaud
,
Danielle Degenne
,
M. Ferrante
,
Anne-Claire Duveau
,
et al.
Digestives Diseases Week San Diego 17-22 mai., May 2008, SAN DIEGO, United States. 134 (4, Supplement 1): A-68
Communication dans un congrès
hal-00320142v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis
Theodora Bejan-Angoulvant
,
David Ternant
,
Fadela Daoued
,
Frédéric Medina
,
Louis Bernard
,
et al.
Article dans une revue
hal-01980809v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentration
Celine Desvignes
,
Soujanya Edupuganti
,
François Darrouzain
,
Anne-Claire Duveau
,
Amy Loercher
,
et al.
Article dans une revue
hal-02372930v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Pharmacokinetics of adalimumab in Crohn’s disease
David Ternant
,
Konstantinos Karmiris
,
Séverine Vermeire
,
Celine Desvignes
,
Nicolas Azzopardi
,
et al.
Article dans une revue
hal-01769822v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Long-term outcomes in patients with PET-predicted poor-responsive HER2-positive breast cancer treated with neoadjuvant bevacizumab added to trastuzumab and docetaxel: 5-year follow-up of the randomised Avataxher study
Benoit Coudert
,
Jean-Yves Pierga
,
Marie-Ange Mouret-Reynier
,
Kaldoun Kerrou
,
Jean-Marc Ferrero
,
et al.
Article dans une revue
hal-03244169v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
An enzyme-linked immunosorbent assay for therapeutic drug monitoring of cetuximab
D. Ternant
,
N. Ceze
,
F. Piller
,
D. Degenne
,
E. Dorval
,
et al.
Fundamental & Clinical Pharmacology, 2009, 23, pp.23-23
Article dans une revue
hal-00616413v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Therapeutic antibodies in ophthalmology Old is new again
Charlotte Magdelaine-Beuzelin
,
Coralie Pinault
,
Gilles Paintaud
,
Herve Watier
Article dans une revue
hal-00616362v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
An Enzyme-Linked Immunosorbent Assay to Study Bevacizumab Pharmacokinetics
David Ternant
,
Nicolas Ceze
,
Thierry Lecomte
,
Danielle Degenne
,
Anne-Claire Duveau
,
et al.
Ther. Drug Monit., 2010, 32 (5), pp.647-652
Article dans une revue
hal-00616329v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Aerosoltherapy for lung tumors using the monoclonal antibody cetuximab
Agnes Maillet
,
Laurent Guilleminault
,
Nicolas Azzopardi
,
Jerome Montharu
,
Laurent Vecellio
,
et al.
Journal of Thoracic Oncology, 2009, 4 (9), pp.S600-S600
Article dans une revue
hal-00616858v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration
David Ternant
,
Christophe Passot
,
Alexandre Aubourg
,
Philippe Goupille
,
Celine Desvignes
,
et al.
Article dans une revue
hal-02372850v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Influence of Antigen Mass on the Pharmacokinetics of Therapeutic Antibodies in Humans
David Ternant
,
Nicolas Azzopardi
,
William Raoul
,
Theodora Bejan-Angoulvant
,
Gilles Paintaud
Article dans une revue
hal-01821717v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial)
Mario Campone
,
Thomas Bachelot
,
Isabelle Treilleux
,
Barbara Pistilli
,
Julia Salleron
,
et al.
Article dans une revue
hal-03469622v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Le Centre Pilote de suivi Biologique des Anticorps thérapeutiques (CePiBac) du CHU de Tours.
Gilles Paintaud
6ème Réunion des Pharmacologues de l'Ouest. Mosnes, Jun 2008, MOSNES, France
Communication dans un congrès
hal-00319009v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Development of anti-infliximab antibodies increases infliximab clearance in chronic Inflammatory Bowel Diseases.
David Ternant
,
Alexandre Aubourg
,
Charlotte Magdelaine-Beuzelin
,
Danielle Degenne
,
Hervé Watier
,
et al.
Immunogenicity for Biologics 2008, IBC Congress, Bâle (Suisse), 5-6 février., Feb 2008, BALE, Switzerland
Communication dans un congrès
hal-00320459v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Rituximab-related late-onset neutropenia in a severe rheumatoid arthritis patient (case report).
H. Marotte
,
Gilles Paintaud
,
Hervé Watier
,
P. Miossec
Annals of the Rheumatic Diseases, 2008, 67, pp.893-894
Article dans une revue
hal-00318083v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Intra-tracheal amikacin spray delivery in healthy mechanically ventilated piglets
Antoine Guillon
,
François Darrouzain
,
Nathalie Heuzé-Vourc'H
,
Antoine Petitcollin
,
Céline Barc
,
et al.
Article dans une revue
hal-02526680v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn’s Disease
David Ternant
,
Zahir Berkane
,
Laurence Picon
,
Valérie Gouilleux-Gruart
,
Jean-Frédéric Colombel
,
et al.
Article dans une revue
hal-02425490v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Pharmacokinetics (PK) of mAbs
Gilles Paintaud
Médecine/Sciences, 2009, 25 (12), pp.1057-1062
Article dans une revue
hal-00616817v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients
Nicolas Azzopardi
,
Therry Lecomte
,
David Ternant
,
Michele Boisdron-Celle
,
Friedrich Piller
,
et al.
Fundamental & Clinical Pharmacology, 2011, 25, pp.34-34
Article dans une revue
hal-00616314v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Rituximab-related late-onset neutropenia in a patient with severe rheumatoid arthritis
Hubert Marotte
,
Gilles Paintaud
,
Herve Watier
,
Pierre Miossec
Annals of the Rheumatic Diseases, 2008, 67 (6), pp.893-894
Article dans une revue
hal-00616939v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Acute Lithium Intoxications, Review of the Literature and Cases Study.
Corinne Schmitt
,
Yves Furet
,
Dominique Perrotin
,
Gilles Paintaud
Thérapie, 2009, 64 (1), pp.55-63
Article dans une revue
hal-00616922v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition
Amina Bensalem
,
Guillaume Cartron
,
Ulrich Specks
,
Denis Mulleman
,
Emmanuel Gyan
,
et al.
Article dans une revue
hal-03482193v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study.
Mira Tout
,
Olivier Casasnovas
,
Michel Meignan
,
Thierry Lamy
,
Franck Morschhauser
,
et al.
Article dans une revue
hal-01547802v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
The underlying inflammatory chronic disease influences infliximab pharmacokinetics
Christophe Passot
,
Denis Mulleman
,
Theodora Bejan-Angoulvant
,
Alexandre Aubourg
,
Stephanie Willot
,
et al.
Article dans une revue
hal-01980816v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial
Emilie Ducourau
,
Theo Rispens
,
Marine Samain
,
Emmanuelle Dernis
,
Fabienne Le Guilchard
,
et al.
Article dans une revue
hal-02439716v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximab
Jérôme Rollin
,
Audrey Payancé
,
Valérie Gouilleux-Gruart
,
Michelle Boisdron-Celle
,
Nicolas Azzopardi
,
et al.
Article dans une revue
hal-02381189v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial
Emilie Ducourau
,
Theo Rispens
,
Marine Samain
,
Emmanuelle Dernis
,
Fabienne Le Guilchard
,
et al.
Article dans une revue
hal-03244823v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study
Melanie Roland
,
Christelle Barbet
,
Gilles Paintaud
,
Charlotte Magdelaine-Beuzelin
,
Elisabeth Diot
,
et al.
Lupus, 2009, 18 (5), pp.441-447
Article dans une revue
hal-00616925v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Mycophenolate mofetil in patients with systemic lupus erythematosus : a prospective pharmacokinetic study.
Gilles Paintaud
,
Charlotte Magdelaine-Beuzelin
,
M. Roland
,
C. Barbet
,
E. Diot
,
et al.
Lupus, 2009, 18, pp.441-447
Article dans une revue
hal-00375656v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|